Retinal vascular changes following intravitreal ranibizumab injections for neovascular AMD over a 1-year period.

Eye
Sanjeewa S WickremasingheSalmaan Qureshi

Abstract

To assess retinal vascular calibre changes in eyes with neovascular age-related macular degeneration (AMD), treated with intravitreal anti-vascular endothelial growth factor agents, over a 1-year period and compare any such changes to untreated fellow eyes. Treatment naïve patients with neovascular AMD received three consecutive intravitreal injections of ranibizumab, followed by a pro re nata dosing regimen up to 1 year, with the aim of maintaining a 'fluid-free' macula. Retinal arteriolar and venular calibre was measured from digital fundus photographs at baseline and at three monthly intervals to 1 year, and summarised as central retinal artery equivalent (CRAE) and central retinal venular equivalent (CRVE), respectively. A total of 53 injected eyes and 41 fellow, non-injected eyes were analysed. At baseline, there were no differences in retinal vascular calibre between injected and non-injected eyes (mean CRAE (SD) 144.93 (14.07) vs 145.74 (13.10) μm, P=0.80 and mean CRVE (SD) 216.23 (25.93) vs 219.91 (22.82) μm, P=0.53). Over a 12-month period, retinal venular calibre dilatation occurred in injected eyes (mean CRVE change +5.71 (14.71) μm, P=0.007), with no change in retinal arterioles, +0.69 (14.71) μm, P=0.68. In non-inj...Continue Reading

References

Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fairooz KabbinavarEmily Bergsland
Jun 26, 2003·Investigative Ophthalmology & Visual Science·Harry LeungPaul Mitchell
Oct 17, 2003·Current Eye Research·Michael D KnudtsonBarbara E K Klein
Oct 16, 2004·Retina·Lloyd P AielloMichael T Trese
Feb 25, 2005·Investigative Ophthalmology & Visual Science·Juan E GrunwaldMaureen G Maguire
Sep 21, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Tomomi KambaDonald M McDonald
Sep 29, 2005·The Journal of Clinical Endocrinology and Metabolism·Charles CouillardNathalie Bergeron
Jan 13, 2006·Archives of Ophthalmology·Ronald KleinMichael Y Tsai
Feb 24, 2006·American Journal of Ophthalmology·Tien Yin WongSteven Shea
May 26, 2006·Investigative Ophthalmology & Visual Science·Tien Yin WongEyal Shahar
Oct 6, 2006·The New England Journal of Medicine·Philip J RosenfeldUNKNOWN MARINA Study Group
Oct 6, 2006·The New England Journal of Medicine·David M BrownUNKNOWN ANCHOR Study Group
Aug 4, 2007·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Lihteh WuUNKNOWN Pan American Collaborative Retina Group (PACORES)
Mar 14, 2008·The New England Journal of Medicine·Vera EreminaSusan E Quaggin
Jan 28, 2009·Survey of Ophthalmology·Cong SunTien Y Wong
Feb 4, 2009·Ophthalmology·Takashi UetaTakuhiro Yamaguchi
Feb 12, 2009·The British Journal of Ophthalmology·H NomaS Hori
Mar 1, 2008·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Young Il ChoiSeong Hoon Shin
May 29, 2010·Stroke; a Journal of Cerebral Circulation·Thanh T NguyenTien Yin Wong
Oct 30, 2010·Stroke; a Journal of Cerebral Circulation·Renske G WieberdinkMonique M B Breteler
Jun 23, 2011·Investigative Ophthalmology & Visual Science·Olivier FontaineMark R Lesk

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.